Jeollabuk-do, South Korea

Ho Cheol Kim


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ho Cheol Kim - Innovator in Chiral Catalysis

Introduction

Ho Cheol Kim is a prominent inventor based in Jeollabuk-do, South Korea. He has made significant contributions to the field of catalysis, particularly in the development of chiral salen catalysts. His work focuses on creating efficient methods for synthesizing chiral compounds, which are essential in various applications, including pharmaceuticals and food additives.

Latest Patents

Ho Cheol Kim holds a patent for a chiral salen catalyst and methods for the preparation of chiral compounds from racemic epoxides using this new catalyst. The invention provides novel chiral salen catalysts that enable the production of chiral compounds with high optical purity. These compounds can be utilized as raw materials for preparing chiral medicines or food additives on a large scale and in an economically viable manner. Notably, the chiral salen catalyst features a specific molecular structure that allows for continuous reuse without the need for activation processes. This innovation minimizes racemization after the reaction, as the catalyst maintains its activity throughout the process.

Career Highlights

Ho Cheol Kim is associated with Rstech Corporation, where he continues to advance his research in catalysis. His work has garnered attention for its practical applications and potential impact on the industry.

Collaborations

He collaborates with notable colleagues, including Geon Joong Kim and Ho Seong Lee, who contribute to his research endeavors and innovations in the field.

Conclusion

Ho Cheol Kim's contributions to chiral catalysis exemplify the importance of innovation in developing efficient and sustainable methods for producing essential compounds. His work not only enhances the field of chemistry but also has significant implications for the pharmaceutical and food industries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…